Ontrak: Q4 Earnings Insights


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


 

Shares of Ontrak (NASDAQ:OTRK) remained unaffected after the company reported Q4 results.

Quarterly Results

Earnings per share increased 86.54% over the past year to ($0.07), which beat the estimate of ($0.30).

Revenue of $29,251,000 rose by 148.78% year over year, which beat the estimate of $29,200,000.

Outlook

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

Price Action

Company's 52-week high was at $99.89

Company's 52-week low was at $35.51

Price action over last quarter: Up 0.19%

Company Profile

Ontrak Inc is an AI and telehealth enabled, virtualized outpatient healthcare treatment company. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsNewsBZI-Recaps